CUBIST PHARMACEUTICALS INC |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2014 | Cubist Pharmaceuticals : sales force seen as potential boon for Merck intestinal drug | RE |
| 2014 | Cubist Pharmaceuticals : Merck says still plans to buy Cubist, despite patent setback | RE |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Karen Rogers
PRN | Corporate Officer/Principal | - | - |
| Sales & Marketing | - | - | |
| Corporate Officer/Principal | - | 96-12-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06-08-31 | |
| Director/Board Member | 70 | 13-09-24 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 76,295,299 | 75,907,820 ( 99.49 %) | 0 | 99.49 % |
Company contact information
Cubist Pharmaceuticals LLC
155 Federal Street Suite 700
02110, Boston
+781-860-8660
http://www.cubist.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| -9.14% | 11.95B | |
| +5.24% | 8.71B | |
| -8.42% | 8.12B |
- Stock Market
- Equities
- Stock
- Company Cubist Pharmaceuticals Inc
